Translational Biochemistry in Precision Medicine: Molecular Targets, Biomarkers, and Therapeutic Strategies

Background: Precision medicine seeks to tailor diagnostics and therapeutics to individual molecular profiles, and translational biochemistry plays a pivotal role in bridging benchside discoveries with clinical application. By elucidating the biochemical underpinnings of disease heterogeneity, translational approaches enable the identification of actionable molecular targets, predictive biomarkers, and personalized treatment strategies across a spectrum of complex disorders. Methods and Results: This review explores how biochemical tools and methodologies are leveraged to advance precision medicine. Molecular profiling through next-generation sequencing, mass spectrometry-based proteomics, and metabolomics has uncovered diverse disease signatures, from oncogenic kinase mutations to metabolic dysregulation in cardiovascular and neurological disorders. Biochemical characterization of these signatures informs the design of targeted inhibitors, antibody–drug conjugates, and RNA-based therapeutics. Biomarkers such as circulating tumor DNA, exosomal RNA, and post-translational modification patterns guide early diagnosis, prognosis, and therapy response monitoring. Integration of biochemical data with computational modeling and clinical phenotyping enhances patient stratification and therapeutic efficacy. Case studies in cancer, rare genetic disorders, and inflammatory diseases illustrate the translational pathway from biomarker discovery to regulatory-approved therapeutics. Emphasis is placed on the development of companion diagnostics, biomarker-driven clinical trials, and the biochemical validation of novel drug targets. Conclusion: Translational biochemistry serves as the molecular engine of precision medicine, enabling the transition from population-level treatments to individualized therapeutic regimens. Continued innovation in biochemical technologies and cross-disciplinary collaboration is essential for realizing the full potential of personalized healthcare.